Cargando…
Effect of dronabinol on progression in progressive multiple sclerosis (CUPID): a randomised, placebo-controlled trial
BACKGROUND: Laboratory evidence has shown that cannabinoids might have a neuroprotective action. We investigated whether oral dronabinol (Δ(9)-tetrahydrocannabinol) might slow the course of progressive multiple sclerosis. METHODS: In this multicentre, parallel, randomised, double-blind, placebo-cont...
Autores principales: | Zajicek, John, Ball, Susan, Wright, David, Vickery, Jane, Nunn, Andrew, Miller, David, Cano, Mayam Gomez, McManus, David, Mallik, Sharukh, Hobart, Jeremy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lancet Pub. Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744749/ https://www.ncbi.nlm.nih.gov/pubmed/23856559 http://dx.doi.org/10.1016/S1474-4422(13)70159-5 |
Ejemplares similares
-
The darts of cupid : and other stories /
por: Templeton, Edith
Publicado: (2002) -
Bioavailability study of dronabinol oral solution versus dronabinol capsules in healthy volunteers
por: Parikh, Neha, et al.
Publicado: (2016) -
Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort
por: Zajicek, John P, et al.
Publicado: (2010) -
Effect of food on the pharmacokinetics of dronabinol oral solution versus dronabinol capsules in healthy volunteers
por: Oh, D Alexander, et al.
Publicado: (2017) -
Proof of Concept Trial of Dronabinol in Obstructive Sleep Apnea
por: Prasad, Bharati, et al.
Publicado: (2013)